The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, our mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage research into commercially viable and investable therapies. We are based on the 12th floor of Guy’s Hospital in central London, with over 170 cell and gene therapy experts, state-of-the art development and viral vector laboratories. We have also built a £55m large-scale GMP manufacturing centre to help bring cell and gene therapies to market in the UK and internationally.
The Cell and Gene Therapy Catapult vision is for the UK to be a global leader in the development, delivery and commercialisation of cell and gene therapy. Where businesses can start, grow and confidently develop advanced therapies, delivering them to patients rapidly, efficiently and effectively.
Our mission is to grow the industry in the UK to substantial and sustainable levels by:
- Accelerating commercialisation of innovation from research
- Complementing industry and academia with unique technical facilities and expertise
- Innovating through collaborations with academic and industry networks
- Facilitating growth of the UK ecosystem by working with industry, the research base, Government, the NHS, industry associations and international organisations